| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.5 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |